Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach
Arterial hypertension (AH) is associated with metabolic disorders in approximately 80% of cases. There is a pandemic of so-called new risk factors, such as insulin resistance and association with systemic type of hyperinsulinemia, abdominal obesity, hyperinsulinemia and a special type of dislipidemy...
Main Authors: | Yu V Zhernakova, G H Sharipova, I E Chazova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2015-03-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/viewFile/29094/pdf |
Similar Items
-
Hypertension treatment features in perimenopausal women
by: Yu V Zhernakova, et al.
Published: (2014-03-01) -
The role of hypersympathycotony in development of arterial hypertensionin patients with metabolic syndrome: potential of pathogenetically sound therapy
by: A S Ametov, et al.
Published: (2004-12-01) -
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial
by: - Giuseppe Derosa, et al.
Published: (2009-03-01) -
COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME
by: E. I. Mananko, et al.
Published: (2016-01-01) -
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
by: Yu V Zhernakova, et al.
Published: (2017-03-01)